Search for: "Myriad Genetics"
Results 181 - 200
of 856
Sort by Relevance
|
Sort by Date
26 Feb 2016, 1:21 pm
Myriad Genetics (2013); and Alice Corporation v. [read post]
14 Jan 2016, 2:58 pm
” Companies that use big data are likely already familiar with the myriad of privacy-related legal issues — data collection and online behavioral tracking, notice and consumer choice, data security, anonymization and de-identification, intra-company data sharing, retail consumer tracking, and many others. [read post]
13 Jan 2016, 9:59 pm
By Claire Gregg & Martin O'Brien -- Following the recent public consultation in view of the Australian High Court's decision in D'Arcy v Myriad Genetics ("Myriad"), IP Australia has released new Examination Guidelines for applications which may be affected by the decision. [read post]
17 Dec 2015, 9:13 am
Biometric data is sensitive data—Genetic data and biometric data, which are used to identify someone, are now “sensitive personal data,” and subject to stricter rules. [read post]
5 Dec 2015, 11:59 pm
These provisions apply particularly to regulated products, including pharmaceuticals and biologics (a.k.a biopharmaceuticals).In this article I will look at three specific aspects of the TPP:the obligation to provide for adjustment of the patent term to compensate for ‘unreasonable delays’ in the grant of a patent, about which I expect Australia to do nothing; the obligation to provide for extensions of the term of patents relating to pharmaceutical products as compensation… [read post]
4 Nov 2015, 1:37 am
The Myriad Genetics saga has been going on for several years now in the Land Down Under, and this writer has been waiting for the Australian High Court decision with bated breath. [read post]
1 Nov 2015, 9:23 pm
Render definitive legal opinions and associated oral advice on a myriad of issues, for which often no legal precedents exist. [read post]
19 Oct 2015, 12:32 pm
* A Myriad of Problems: Genetic Patents Refused by High Court of AustraliaIf years of highly visible US litigation was not enough to satiate your taste for gene patent cases, unbeknownst to some readers Myriad Genetics [Katposts here and here, among several others] have been going through another similar saga in Australia, pertaining to the very same patents that were so hotly contested in the US. [read post]
18 Oct 2015, 12:24 am
Myriad Genetics, Inc, which the US Office treated as affecting the patent-eligibility of all claims directed or relating to natural products. [read post]
16 Oct 2015, 1:50 am
Myriad Genetics had acquired a patent for the isolation and subsequent analysis of the genetic sequence [Australian patent no. [read post]
11 Oct 2015, 5:00 am
The post PTO Report on Confirmatory Genetic Testing: A Worthwhile Effort But Not Far Enough appeared first on IPWatchdog.com | Patents & Patent Law. [read post]
8 Oct 2015, 9:14 pm
In particular, all seven High Court judges found that claims 1-3 of Myriad Genetics’ Australian patent no. 686004, each of which is directed to isolated nucleic acid molecules corresponding with the BRCA mutation associated with increased breast cancer risk, are invalid because they do not define a patent-eligible ‘manner of manufacture’ under Australian law: D'Arcy v Myriad Genetics Inc [2015] HCA 35.In arriving at this ruling, the… [read post]
8 Oct 2015, 8:09 am
The view that genes could be patented suffered a major defeat in 2013, when the US Supreme Court struck down Myriad Genetics' patents on the genes BRCA1 and the similar BRCA2. [read post]
7 Oct 2015, 10:00 pm
Myriad Genetics Inc. [read post]
7 Oct 2015, 9:59 pm
Myriad Genetics Inc & Anor [2015] HCA 35 By Claire Gregg & Martin O'Brien -- The High Court of Australia today handed down its decision in D'Arcy v Myriad, deciding once and for all that isolated nucleic acids do not define patent-eligible subject matter in Australia. [read post]
7 Oct 2015, 9:53 pm
D'Arcy v Myriad Genetics Inc [2015] HCA 35 By Bindhu Holavanahalli* and Gary Cox** -- The High Court of Australia has today handed down its decision in D'Arcy v Myriad Genetics Inc [2015] HCA 35, unanimously striking down the validity of the first three claims of Myriad Genetics Inc's (Myriad) patent. [read post]
6 Oct 2015, 5:17 pm
D’Arcy v Myriad Genetics Inc (S28-2015) [2015] HCA 35. [read post]
1 Sep 2015, 9:30 pm
As an example, they emphasize that prior to the Supreme Court’s invalidation of Myriad Genetics’ patents on the BRCA1 and BRCA2 genes in 2013, just one lab could legally sequence those genes. [read post]
30 Aug 2015, 5:52 pm
Sequenom’s patents focus on methods of prenatal genetic diagnoses that rely upon these discovery by the inventors. [read post]
14 Aug 2015, 9:15 am
The patents that are due to expire include Australian patent AU686004, the subject of D'Arcy v Myriad Genetics Inc & Another, as well as a number of the European BRCA patents (EP0699754, EP0705902 and EP0705903). [read post]
